Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.203
+0.003 (0.25%)
At close: Sep 5, 2025, 4:00 PM
1.180
-0.023 (-1.91%)
After-hours: Sep 5, 2025, 5:08 PM EDT

Evogene Statistics

Total Valuation

Evogene has a market cap or net worth of $10.82 million. The enterprise value is $17.74 million.

Market Cap10.82M
Enterprise Value 17.74M

Important Dates

The last earnings date was Tuesday, August 19, 2025, before market open.

Earnings Date Aug 19, 2025
Ex-Dividend Date n/a

Share Statistics

Evogene has 8.71 million shares outstanding. The number of shares has increased by 32.58% in one year.

Current Share Class 8.71M
Shares Outstanding 8.71M
Shares Change (YoY) +32.58%
Shares Change (QoQ) +6.29%
Owned by Insiders (%) 0.99%
Owned by Institutions (%) 1.85%
Float 8.63M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.15
Forward PS 1.80
PB Ratio 0.87
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.88
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.21.

Current Ratio 1.89
Quick Ratio 0.89
Debt / Equity 0.21
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -20.26

Financial Efficiency

Return on equity (ROE) is -98.38% and return on invested capital (ROIC) is -66.04%.

Return on Equity (ROE) -98.38%
Return on Assets (ROA) -31.55%
Return on Invested Capital (ROIC) -66.04%
Return on Capital Employed (ROCE) -100.92%
Revenue Per Employee $80,718
Profits Per Employee -$121,821
Employee Count117
Asset Turnover 0.25
Inventory Turnover 2.68

Taxes

In the past 12 months, Evogene has paid $9,000 in taxes.

Income Tax 9,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -60.56% in the last 52 weeks. The beta is 1.42, so Evogene's price volatility has been higher than the market average.

Beta (5Y) 1.42
52-Week Price Change -60.56%
50-Day Moving Average 1.29
200-Day Moving Average 1.37
Relative Strength Index (RSI) 42.81
Average Volume (20 Days) 50,043

Short Selling Information

Short Interest 156,489
Short Previous Month 174,433
Short % of Shares Out 1.80%
Short % of Float n/a
Short Ratio (days to cover) 1.82

Income Statement

In the last 12 months, Evogene had revenue of $9.44 million and -$14.25 million in losses. Loss per share was -$2.14.

Revenue9.44M
Gross Profit 5.75M
Operating Income -18.90M
Pretax Income -21.46M
Net Income -14.25M
EBITDA -17.33M
EBIT -18.90M
Loss Per Share -$2.14
Full Income Statement

Balance Sheet

The company has $11.69 million in cash and $2.66 million in debt, giving a net cash position of $9.03 million or $1.04 per share.

Cash & Cash Equivalents 11.69M
Total Debt 2.66M
Net Cash 9.03M
Net Cash Per Share $1.04
Equity (Book Value) 12.38M
Book Value Per Share -0.49
Working Capital 13.45M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.62 million and capital expenditures -$583,000, giving a free cash flow of -$18.20 million.

Operating Cash Flow -17.62M
Capital Expenditures -583,000
Free Cash Flow -18.20M
FCF Per Share -$2.09
Full Cash Flow Statement

Margins

Gross margin is 60.93%, with operating and profit margins of -200.17% and -150.92%.

Gross Margin 60.93%
Operating Margin -200.17%
Pretax Margin -168.21%
Profit Margin -150.92%
EBITDA Margin -183.48%
EBIT Margin -200.17%
FCF Margin n/a

Dividends & Yields

Evogene does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -32.58%
Shareholder Yield -32.58%
Earnings Yield -131.70%
FCF Yield -168.18%

Analyst Forecast

The average price target for Evogene is $3.50, which is 190.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target $3.50
Price Target Difference 190.94%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on July 25, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date Jul 25, 2024
Split Type Reverse
Split Ratio 1:10

Scores

Altman Z-Score n/a
Piotroski F-Score 2